| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Hcw Biologics Inc. (HCWB) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. HCWB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 615.8K | $683.5K | - | |
| Dir | 203.4K | $225.8K | - | |
| CFO | 57.2K | $63.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 | Garrett Scott T | Director | Buy | 177,936 | $1.41 | $250,000.08 | +697.7% | - | - | |
| May 22, 2026 | Wong Hing C | Chief Executive Officer | Buy | 113,879 | $1.41 | $160,000.00 | +22.7% | - | - | |
| May 22, 2026 | Byam Rebecca | Chief Financial Officer | Buy | 14,235 | $1.41 | $20,000.18 | +33.1% | - | - | |
| May 16, 2025 | Wong Hing C | Chief Executive Officer | Buy | 8,054 | $7.45 | $60,002.30 | +1.6% | -51.5% | -86.4% | |
| May 16, 2025 | Winer Gary M53 | Director | Buy | 1,342 | $7.45 | $9,997.90 | +49.1% | -51.5% | -86.4% | |
| May 16, 2025 | Garrett Scott T | Director | Buy | 13,423 | $7.45 | $100,001.35 | +111.1% | -51.5% | -86.4% | |
| May 8, 2025 | Wong Hing C | Chief Executive Officer | Buy | 92,500 | $26.00 | $2,405,000.00 | +23.0% | -36.8% | -95.4% | |
| May 8, 2025 | Winer Gary M53 | Director | Buy | 2,308 | $26.00 | $60,008.00 | +543.1% | -36.8% | -95.4% | |
| May 8, 2025 | Garrett Scott T | Director | Buy | 5,385 | $26.00 | $140,010.00 | +80.4% | -36.8% | -95.4% | |
| May 8, 2025 | Byam Rebecca | Chief Financial Officer | Buy | 8,462 | $26.00 | $220,012.00 | +24.5% | -36.8% | -95.4% |